Ching-Feng Chiu

10PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technologyCancer cell biologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 20, 2025
Correction: Chiu et al. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers 2024, 16, 3513.

Ching-Feng Chiu, Jonathan Jaime G Guerrero, Ric Ryan H Regalado

|Nov 09, 2024
The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer.

Ching-Feng Chiu, Hui-Ru Lin, Yen-Hao Su

|Oct 26, 2024
Insights into Metabolic Reprogramming in Tumor Evolution and Therapy.

Ching-Feng Chiu, Jonathan Jaime G Guerrero, Ric Ryan H Regalado

|Aug 21, 2024
Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape.

Tung-Wei Hsu, Wan-Yu Wang, Alvin Chen

|Jan 21, 2023
A Mitochondrion-Targeting Protein (B2) Primes ROS/Nrf2-Mediated Stress Signals, Triggering Apoptosis and Necroptosis in Lung Cancer.

Hsuan-Wen Chiu, Shao-Wen Hung, Ching-Feng Chiu

|Jan 11, 2022
TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer.

Jie-Ning Li, Pai-Sheng Chen, Ching-Feng Chiu

Pageof 2

Frequent Collaborators

5 joint publications

Shih-Yi Huang

2 joint publications

Cidne Danielle D Carles

2 joint publications

Jiayan Zhou

2 joint publications

Charupong Saengboonmee